Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study

NCT01816503 · clinicaltrials.gov ↗

COMPLETED

Status

636

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: No intervention

Sponsor

Janssen Korea, Ltd., Korea